Anthem Blue Cross and Blue Shield | CommercialJanuary 22, 2025
Breast Cancer Screening (BCS-E) 2025
HEDIS® is a widely used set of performance measures developed and maintained by the National Committee for Quality Assurance (NCQA). These are used to drive improvement efforts surrounding best practices.
The HEDIS quality measures reported using the Electronic Clinical Data Systems (ECDS) inspire innovative use of electronic clinical data to document high-quality patient care, demonstrating commitment to evidence-based practices. Organizations that report HEDIS using ECDS encourage the electronic exchange of the information needed to provide high-quality services, ensuring that the information reaches the right people at the right time.
HEDIS measure
This measure looks at patients 50 to 74 years old who were recommended for routine breast cancer screening and had a mammogram to screen for breast cancer from October 1, two years before the measurement period through the end of the measurement period.
Refer to attachment to view full details
HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA).
Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of Maine, Inc. Independent licensee of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.
MULTI-BCBS-CM-075652-24-CPN74732
ATTACHMENTS: Breast Cancer Screening (BCS-E) 2025 (pdf - 1.27mb)
To view this article online:
Visit https://providernews.anthem.com/maine/articles/breast-cancer-screening-bcs-e-2025-23786
Or scan this QR code with your phone